Reviva Pharmaceuticals Holdings, Inc.
NASDAQ: RVPH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Laxminarayan Bhat
- Employees
- 14
- Headquarters
- Cupertino, United States
- IPO year
- 2018
- Market cap
- $2.1M
- Website
- https://revivapharma.com
Loading RVPH…
Loading profile data…Frequently asked questions about RVPH
What does Reviva Pharmaceuticals Holdings, Inc. (RVPH) do?
Reviva Pharmaceuticals Holdings, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to advancing novel therapeutic solutions. The company strives to identify, develop, and commercialize treatments that address significant unmet medical needs across various therapeutic areas, including disorders of the central nervou...
Where does RVPH trade?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) trades on the NASDAQ Capital Market.
What sector is RVPH in?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Reviva Pharmaceuticals Holdings, Inc.?
Laxminarayan Bhat is the chief executive officer of Reviva Pharmaceuticals Holdings, Inc. (RVPH).
Where is Reviva Pharmaceuticals Holdings, Inc. headquartered?
Reviva Pharmaceuticals Holdings, Inc. is headquartered in United States.
Does RVPH pay a dividend?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RVPH go public?
Reviva Pharmaceuticals Holdings, Inc. (RVPH) completed its initial public offering in 2018.